Pharmaceutical strategies in the emerging era of antibody-based biotherapeutics for the treatment of cancers overexpressing MET receptor tyrosine kinase
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference100 articles.
1. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy;Comoglio;Nat. Rev. Cancer,2018
2. The human met oncogene is related to the tyrosine kinase oncogenes;Dean;Nature,1985
3. Hepatocyte growth factor/MET in cancer progression and biomarker discovery;Matsumoto;Cancer Sci.,2017
4. Targeting MET in cancer: rationale and progress;Gherardi;Nat. Rev. Cancer,2012
5. MET-dependent solid tumours - molecular diagnosis and targeted therapy;Guo;Nat. Rev. Clin. Oncol.,2020
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination;Cancers;2023-05-13
2. Drug Discovery from Natural Sources;Current Pharmacology Reports;2023-02-27
3. THE PRECLINICAL JOURNEY OF MET INHIBITORS;2022 Medicinal Chemistry Reviews;2022-12-21
4. Natural products and drug discovery;National Science Review;2022-09-29
5. Antibody-Drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase;Current Cancer Drug Targets;2021-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3